[Overview on hypoglycemic active constituents of traditional Chinese medicine based on insulin receptor signaling pathway].

Lyu, Hua-Wei; Luo, Meng; Li, Yu-Xia; Jiang, Heng-Pei; Yan, Ji-Zhong; Tong, Sheng-Qiang

Lyu, Hua-Wei; Luo, Meng; Li, Yu-Xia; Jiang, Heng-Pei; Yan, Ji-Zhong; Tong, Sheng-Qiang.

Afiliação

Lyu HW; College of Pharmacy,Zhejiang University of Technology Hangzhou 310014,China.
Luo M; College of Pharmacy,Zhejiang University of Technology Hangzhou 310014,China.
Li YX; College of Pharmacy,Zhejiang University of Technology Hangzhou 310014,China.
Jiang HP; Lvgu Biological Pharmaceutical Co.,Ltd. Lishui 323000,China.
Yan JZ; College of Pharmacy,Zhejiang University of Technology Hangzhou 310014,China.
Tong SQ; College of Pharmacy,Zhejiang University of Technology Hangzhou 310014,China.

Zhongguo Zhong Yao Za Zhi ; 44(19): 4158-4164, 2019 Oct.

Article em Zh | MEDLINE | ID: mdl-31872693

Assuntos

Hipoglicemiantes/uso terapêutico; Resistência à Insulina; Medicina Tradicional Chinesa; Receptor de Insulina/metabolismo; Diabetes Mellitus Tipo 2; Humanos; Insulina; Proteínas Substratos do Receptor de Insulina; Fosfatidilinositol 3-Quinases; Fosforilação; Proteínas Proto-Oncogênicas c-akt; Transdução de Sinais

Palavras-chave

active ingredients; insulin receptor signaling pathway; insulin resistance; traditional Chinese medicine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Receptor de Insulina / Hipoglicemiantes / Medicina Tradicional Chinesa Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: Zh Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google